
X
Scotland backs Pfizer’s Ibrance for breast cancer
https://pharmaphorum.com/news/scotland-backs-pfizers-ibrance-for-breast-cancer/
The latest news, views and analysis from the pharmaceutical industry’s frontline in the war on cancer. Updates on pharmaceutical and biotech oncology pipelines, regulatory decisions and market access news, and how healthcare systems needs to change to tackle one of the world’s biggest killers.
Bayer and the University of Texas MD Anderson Cancer Center have signed a five-year collaboration agreement to accelerate the development of novel targeted treatments for cancer.